| LIPI Stock | | | SEK 0.19 0.00 0.00% |
CEO
Ola Holmlund is Chief Executive Officer of Lipidor Ab since 2018.
| Age | 54 |
| Tenure | 6 years |
| Phone | 46 7 25 07 03 69 |
| Web | https://lipidor.se |
Lipidor Ab Management Efficiency
The company has return on total asset
(ROA) of
(0.6425) % which means that it has lost $0.6425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(1.3463) %, meaning that it generated substantial loss on money invested by shareholders. Lipidor Ab's management efficiency ratios could be used to measure how well Lipidor Ab manages its routine affairs as well as how well it operates its assets and liabilities.
Lipidor AB , a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, bacterial skin infections, and atopic dermatitis. Lipidor AB was founded in 2009 and is based in Stockholm, Sweden. Lipidor AB is traded on Stockholm Stock Exchange in Sweden. Lipidor Ab (LIPI) is traded on Stockholm Exchange in Sweden and employs 6 people.
Management Performance
Lipidor Ab Leadership Team
Elected by the shareholders, the Lipidor Ab's board of directors comprises two types of representatives: Lipidor Ab inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lipidor. The board's role is to monitor Lipidor Ab's management team and ensure that shareholders' interests are well served. Lipidor Ab's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lipidor Ab's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Charlotta Ekman, Chief Officer | |
| Olle Holmertz, Founder Controller | |
| Ola Flink, Independent Chairman of the Board | |
| Gunilla Lundmark, Independent Director | |
| Per Nilsson, Director | |
| Fredrik Sjovall, Independent Director | |
| Jan Holmback, Research Director | |
| Anders Hagman, Chief Officer | |
| Anders Carlsson, Sr CoFounder | |
| Bengt Herslf, Cofounder Advisor | |
| Jan Holmbck, CoFounder Officer | |
| Ola Holmlund, Chief Executive Officer | |
| Michael Owens, Chief Financial Officer | |
| Gerhard Miksche, CoFounder | |
| Gabriel Haering, Director | |
Lipidor Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Lipidor Ab a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Lipidor Stock Analysis
When running Lipidor Ab's price analysis, check to
measure Lipidor Ab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipidor Ab is operating at the current time. Most of Lipidor Ab's value examination focuses on studying past and present price action to
predict the probability of Lipidor Ab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipidor Ab's price. Additionally, you may evaluate how the addition of Lipidor Ab to your portfolios can decrease your overall portfolio volatility.